ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
종목 코드 RSLS
회사 이름ReShape Lifesciences Inc
상장일Oct 06, 2016
CEOMr. Paul F. Hickey
직원 수17
유형Ordinary Share
회계 연도 종료Oct 06
주소1001 Calle Amanecer
도시SAN CLEMENTE
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호92673
전화19494296680
웹사이트https://www.reshapelifesciences.com/obalon/
종목 코드 RSLS
상장일Oct 06, 2016
CEOMr. Paul F. Hickey
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음